Literature DB >> 20810028

Functional neural stem cell isolation from brains of adult mutant SOD1 (SOD1(G93A)) transgenic amyotrophic lateral sclerosis (ALS) mice.

Jae Chul Lee1, Younggeon Jin, Juyoun Jin, Bong Gu Kang, Do-Hyun Nam, Kyeung Min Joo, Choong Ik Cha.   

Abstract

OBJECTIVES: The aim of present study is to investigate more functional neural stem cells (NSCs) could be isolated from brains with amyotrophic lateral sclerosis (ALS) and expanded in vitro, based on previous reports demonstrating de novo neurogenesis is enhanced to replace degenerating neural tissue.
METHODS: Thirteen- or eighteen-week-old mutant human Cu/Zn superoxide dismutase (SOD1(G93A)) transgenic ALS and wild-type SOD1 transgenic control mice were utilized. Changes in numbers of NSCs in the dentate gyrus were analyzed by immunohistochemistry against nestin and CD133. NSCs were primarily cultured from hippocampus of ALS or control mice. Expression of NSC markers, in vitro expansion capacity, and differentiating potential were compared.
RESULTS: Hippocampus of 13-week-old pre-symptomatic ALS mice harbor more cells that can be propagated for more than 12 passages in vitro, compared with same age control mice. Primarily-cultured cells formed neurospheres in the NSC culture medium, expressed NSC markers, and differentiated into cells with differentiated neural cell characteristics in the differentiation condition confirming that they are NSCs. In contrast, long-term expansible NSCs could not be derived from brains of 18-week-old symptomatic ALS mice with the same experimental techniques, although they had comparable nestin-immunoreactive cells in the dentate gyrus. DISCUSSION: These results would suggest that increased neuroregeneration in early phase of ALS could be translated to regenerative approaches; however, long-term exposure to ALS microenvironments could abolish functional capacities of NSCs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20810028     DOI: 10.1179/016164110X12807570509899

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  6 in total

1.  Adult neurogenesis and neurodegenerative diseases: A systems biology perspective.

Authors:  Emrin Horgusluoglu; Kelly Nudelman; Kwangsik Nho; Andrew J Saykin
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-02-16       Impact factor: 3.568

2.  Cultivating stem cells for treating amyotrophic lateral sclerosis.

Authors:  Shengwen Calvin Li; Hong Zhen Yin; William G Loudon; John H Weiss
Journal:  World J Stem Cells       Date:  2012-12-26       Impact factor: 5.326

3.  Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis.

Authors:  Yazhou Li; Srinivasulu Chigurupati; Harold W Holloway; Mohamed Mughal; David Tweedie; Daniel A Bruestle; Mark P Mattson; Yun Wang; Brandon K Harvey; Balmiki Ray; Debomoy K Lahiri; Nigel H Greig
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

4.  Up-regulation of neural and cell cycle-related microRNAs in brain of amyotrophic lateral sclerosis mice at late disease stage.

Authors:  Stefania Marcuzzo; Silvia Bonanno; Dimos Kapetis; Claudia Barzago; Paola Cavalcante; Sara D'Alessandro; Renato Mantegazza; Pia Bernasconi
Journal:  Mol Brain       Date:  2015-01-28       Impact factor: 4.041

5.  CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs.

Authors:  Lixia Wang; Fei Yi; Lina Fu; Jiping Yang; Si Wang; Zhaoxia Wang; Keiichiro Suzuki; Liang Sun; Xiuling Xu; Yang Yu; Jie Qiao; Juan Carlos Izpisua Belmonte; Ze Yang; Yun Yuan; Jing Qu; Guang-Hui Liu
Journal:  Protein Cell       Date:  2017-04-11       Impact factor: 14.870

6.  Two outward potassium current types are expressed during the neural differentiation of neural stem cells.

Authors:  Ruiying Bai; Guowei Gao; Ying Xing; Hong Xue
Journal:  Neural Regen Res       Date:  2013-10-05       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.